-
2023-509630-19-00
5
2025-07-31
Esophageal Squamous Cell Carcinoma (ESCC)
-
2024-512583-57-00
5
2025-07-30
HER2-positive locally advanced or metastatic gastric or gastroesophage
-
2024-518893-15-00
5
2025-07-29
Chronic lymphotic leukemia and Small Lymphocytic lymphoma
-
2024-515884-69-00
5
2025-07-16
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
-
2024-513682-40-01
5
2025-07-04
Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer
-
2023-509055-14-00
4
2025-06-17
myelodysplastic neoplasia (MDS)
-
2024-515764-31-00
10
2025-06-13
Non-small cell lung cancer
-
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
-
2024-513122-27-00
5
2025-06-10
Unresectable, Locally Advanced or Metastatic HER2 positive Gastric or
-
2024-512302-25-00
5
2025-06-06
Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
-
2024-515526-89-00
4
2025-05-16
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2024-517513-32-00
5
2025-05-16
Sjögren’s Syndrome
-
2024-515593-27-00
5
2025-05-08
relapsed or refractory mantle cell lymphoma (R/R MCL)
-
2024-516030-35-00
5
2025-04-30
Multiple myeloma
-
2023-507878-41-00
4
2025-04-25
Acute myeloid leukemia
-
2024-516173-76-01
5
2025-04-22
HER2-positive or HER2-low (incl. ultra-low) early breast cancer
-
2024-515279-37-00
5
2025-04-17
Relapsed or Refractory and Lenalidomide exposed Multiple Myeloma
-
2023-505789-27-00
4
2025-04-14
Relapsed or Refractory Non-Hodgkin Lymphoma
-
2024-512876-37-00
5
2025-04-11
Peripheral Arterial Disease (PAD)
-
2023-508076-11-00
5
2025-04-01
Colon cancer staged T3-4 and/or nodal positive by CT and/or MRI scan w
-
2022-500574-34-00
4
2025-03-21
Waldenström’s Macroglobulinemia
-
2022-502352-31-00
5
2025-02-10
Colorectal Cancer (CRC)
-
2023-509292-17-00
4
2024-11-08
primary high-risk lobular breast cancer
-
2023-509912-27-00
5
2024-11-07
Metabolic Dysfunction-Associated Steatotic Liver Disease(MASH) / Nonal